CRL — Charles River Laboratories International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapContrarian

Market Cap
$5.63bn
Enterprise Value
$7.73bn
Revenue
$4.05bn

Annual balance sheet for Charles River Laboratories International, fiscal year end - December 28th, USD millions except per share, conversion factor applied.

	2020 December 26th	2021 December 25th	2022 December 31st	2023 December 30th	2024 December 28th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	229	242	235	277	195
Net Total Accounts Receivable
Net Total Receivables	618	650	752	780	721
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,201	1,274	1,439	1,609	1,403
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,303	1,584	1,857	2,034	2,017
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	5,491	7,024	7,603	8,195	7,528
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	840	1,033	1,092	1,055	994
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,376	4,489	4,626	4,598	4,067
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,115	2,535	2,976	3,597	3,462
Total Liabilities & Shareholders' Equity	5,491	7,024	7,603	8,195	7,528
Total Common Shares Outstanding